PUBLICATIONS · 34339292
Amivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2021 Oct 20
- First author
- Park K
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2021 Oct 20;39(30):3403-3406. doi: 10.1200/JCO.21.01494.
- note
- Source null
- related pmid
- 34339261
- relationship
- Comment in
- citation
- Nat Rev Clin Oncol. 2021 Oct;18(10):604. doi: 10.1038/s41571-021-00551-8.
- note
- Source null
- related pmid
- 34381206
- relationship
- Comment in
Authors and identifiers
- name
- Park K
- type
- Author
- name
- Haura EB
- type
- Author
- name
- Leighl NB
- type
- Author
- name
- Mitchell P
- type
- Author
- name
- Shu CA
- type
- Author
- name
- Girard N
- type
- Author
- name
- Viteri S
- type
- Author
- name
- Han JY
- type
- Author
- name
- Kim SW
- type
- Author
- name
- Lee CK
- type
- Author
- name
- Sabari JK
- type
- Author
- name
- Spira AI
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Park K
- type
- Author
- name
- Haura EB
- type
- Author
- name
- Leighl NB
- type
- Author
- name
- Mitchell P
- type
- Author
- name
- Shu CA
- type
- Author
- name
- Girard N
- type
- Author
- name
- Viteri S
- type
- Author
- name
- Han JY
- type
- Author
- name
- Kim SW
- type
- Author
- name
- Lee CK
- type
- Author
- name
- Sabari JK
- type
- Author
- name
- Spira AI
- type
- Author
- bibliography ids
- nci-bib-a3d6ec3c5cb84ae0bd3dc969
- book metadata
- content sha256
- 07411defe5cc44874dfdf44006e209b00382665ac925d828a0778a5f53a481cd
- document type
- citation
- dois
- 10.1200/JCO.21.00662
- electronic publication date
- display
- 2021 Aug 2
- precision
- day
- year
- 2021
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:34339292
- immutable id
- pubmed:34339292@07411defe5cc44874dfdf44006e209b00382665ac925d828a0778a5f53a481cd
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 30
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 3391-3402
- volume
- 39
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- J Clin Oncol. 2021 Oct 20;39(30):3403-3406. doi: 10.1200/JCO.21.01494.
- note
- Source null
- related pmid
- 34339261
- relationship
- Comment in
- citation
- Nat Rev Clin Oncol. 2021 Oct;18(10):604. doi: 10.1038/s41571-021-00551-8.
- note
- Source null
- related pmid
- 34381206
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 34339292
- provenance
- batch id
- 192b6392c165c6b06274
- provider
- NCBI PubMed ESummary
- record sha256
- af182787b3d6139d42033316e9b16c1e8e894600c6172ee9d317545f0c5d0f7e
- response sha256
- 7d81e9fb11ee99e6ad4116aecd61ba71cd6bf76f2a8f8f6d15c5c85e9c6c56b4
- retrieved at
- 2026-09-09T23:48:02.713075+00:00
- publication date
- display
- 2021 Oct 20
- precision
- day
- year
- 2021
- publication types
- Clinical Trial, Phase I
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Amivantamab in EGFR Exon 20 Insertion-Mutated Non-Small-Cell Lung Cancer Progressing on Platinum Chemotherapy: Initial Results From the CHRYSALIS Phase I Study.
Preserved source evidence · Not medical advice
Triangle